Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About SNPS Interactive Breakdown Better Bets vs. SNPS Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Synopsys (SNPS)

Market Price (11/2/2025): $453.0 | Market Cap: $72.6 Bil
Sector: Information Technology | Industry: Application Software

Synopsys (SNPS)

Market Price (11/2/2025): $453.0
Market Cap: $72.6 Bil
Sector: Information Technology
Industry: Application Software

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 22%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 20%		 Weak multi-year price returns
2Y Excs Rtn is -67%, 3Y Excs Rtn is -24%		 Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 50x
0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 22%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 20%
1 Weak multi-year price returns
2Y Excs Rtn is -67%, 3Y Excs Rtn is -24%
2 Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 50x

Market Valuation & Key Metrics

SNPSS&P 500
REVENUE GROWTHFAIR
Rev LTM ($ Bil)6.4
Rev Chg Q14.0%6.6%
Rev Chg LTM8.0%5.4%
Rev Chg 3Y Avg9.7%5.3%
PROFITABILITYGOOD
Op Inc LTM ($ Bil)1.1
CFO LTM ($ Bil)1.4
Net Inc LTM ($ Bil)2.0
Op Mgn LTM17.2%18.7%
CFO/Rev LTM22.4%20.3%
Net Inc Mgn31.0%12.8%
VALUATIONVERY HIGH
P/S11.33.2
P/CFO50.315.1
P/FCF55.720.4
P/E36.323.6
STABILITYGOOD
Debt/Equity0.210.21
Cash/Assets0.050.07

AI Generated Analysis | Feedback

MetricValueDateSource
Backlog N/A/N/A/N/ALink
EDA Market Share 4/21/2023Link
Number of Companies Using Synopsys N/A/N/A/N/ALink

SNPS Stock

   
   
   
   
   
   
   

Why The Stock Moved

Qualitative Assessment

AI Generated Analysis | Feedback

null

Show more

Stock Movement Drivers

Fundamental Drivers

The -3.9% change in SNPS stock from 5/3/2025 to 11/1/2025 was primarily driven by a -10.7% change in the company's Net Income Margin (%).
503202511012025Change
Stock Price ($)472.28453.82-3.91%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)6071.766435.305.99%
Net Income Margin (%)34.75%31.04%-10.67%
P/E Multiple34.5636.395.28%
Shares Outstanding (Mil)154.41160.17-3.73%
Cumulative Contribution-4.04%

LTM = Last Twelve Months as of date shown

Market Drivers

5/3/2025 to 11/1/2025
ReturnCorrelation
SNPS-3.9% 
Market (SPY)20.7%28.6%
Sector (XLK)39.0%20.9%

Fundamental Drivers

The -12.5% change in SNPS stock from 11/1/2024 to 11/1/2025 was primarily driven by a -31.4% change in the company's P/E Multiple.
1101202411012025Change
Stock Price ($)518.40453.82-12.46%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)5958.836435.308.00%
Net Income Margin (%)25.15%31.04%23.44%
P/E Multiple53.0836.39-31.44%
Shares Outstanding (Mil)153.42160.17-4.40%
Cumulative Contribution-12.63%

LTM = Last Twelve Months as of date shown

Market Drivers

11/1/2024 to 11/1/2025
ReturnCorrelation
SNPS-12.5% 
Market (SPY)20.6%47.2%
Sector (XLK)35.0%46.5%

Fundamental Drivers

The 61.4% change in SNPS stock from 11/2/2022 to 11/1/2025 was primarily driven by a 48.8% change in the company's Net Income Margin (%).
1102202211012025Change
Stock Price ($)281.11453.8261.44%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)4949.676435.3030.01%
Net Income Margin (%)20.86%31.04%48.80%
P/E Multiple41.6436.39-12.61%
Shares Outstanding (Mil)152.94160.17-4.73%
Cumulative Contribution61.08%

LTM = Last Twelve Months as of date shown

Market Drivers

11/2/2023 to 11/1/2025
ReturnCorrelation
SNPS-5.2% 
Market (SPY)62.0%53.6%
Sector (XLK)79.1%56.3%

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
SNPS Return86%42%-13%61%-6%-9%233%
Peers Return39%23%-13%50%-4%44%207%
S&P 500 Return16%27%-19%24%23%16%112%

Monthly Win Rates [3]
SNPS Win Rate67%67%42%75%50%56% 
Peers Win Rate35%33%23%37%35%44% 
S&P 500 Win Rate58%75%42%67%75%70% 

Max Drawdowns [4]
SNPS Max Drawdown-22%-16%-29%-1%-10%-22% 
Peers Max Drawdown-15%-8%-27%-2%-16%-15% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: AMD, ADSK, RMBS, BIYA, BLIV. See SNPS Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/31/2025 (YTD)

How Low Can It Go

Unique KeyEventSNPSS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-30.6%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven44.0%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven91 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-34.3%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven52.1%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven58 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-22.9%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven29.7%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven58 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-49.1%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven96.3%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven811 days1480 days

Compare to AMD, ADSK, RMBS, BIYA, BLIV


In The Past

Synopsys's stock fell -30.6% during the 2022 Inflation Shock from a high on 12/27/2021. A -30.6% loss requires a 44.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Synopsys (SNPS)

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

Better Bets than Synopsys (SNPS)

 SNPSBetter Performance than SNPS
MetricValueIndustry (Application Software)
Rev Chg LTM8.0%ORCL (9.7%), PLTR (38.8%), SAP (9.7%), CRM (8.3%), SHOP (29.0%)
Rev Chg 3Y Avg9.7%ORCL (10.2%), PLTR (25.7%), CRM (10.5%), SHOP (26.0%), INTU (14.0%)
Op Mgn LTM17.2%ORCL (31.6%), SAP (26.4%), CRM (21.2%), INTU (26.2%), ADBE (36.2%)
CFO/Rev LTM22.4%ORCL (36.5%), PLTR (50.3%), CRM (33.3%), INTU (33.0%), ADBE (42.2%)
FCF/Rev LTM20.2%PLTR (49.7%), CRM (31.6%), INTU (32.3%), ADBE (41.4%), CDNS (28.4%)
Total Yield2.7%CRM (3.1%), ADBE (4.8%), MSTR (6.5%), ZM (4.5%), SSNC (5.3%)
 SNPSBetter Performance than SNPS
MetricValueAll Other Sectors
Rev Chg LTM8.0%GOOGL (13.4%), AMZN (10.9%), META (21.3%), JPM (8.2%), LLY (36.8%)
Rev Chg 3Y Avg9.7%GOOGL (11.0%), AMZN (11.3%), META (17.3%), JPM (13.5%), LLY (23.4%)
Op Mgn LTM17.2%GOOGL (32.2%), META (43.2%), LLY (43.0%), V (66.5%), MA (58.3%)
CFO/Rev LTM22.4%GOOGL (39.3%), META (56.8%), V (60.4%), MA (56.1%), JNJ (26.3%)
FCF/Rev LTM20.2%META (23.7%), V (56.8%), MA (52.5%), NFLX (20.7%), JNJ (20.3%)
Total Yield2.7%GOOGL (3.9%), META (3.9%), JPM (6.5%), WMT (3.5%), V (3.8%)
 Best Bets In Information Technology Sector
 SNPSVRSN NVDA RMBS YOU GEN IDCC DBX QCOM MPWR CRUS
What You Pay           
P/E36.427.657.048.416.127.218.816.317.125.919.6
P/EBIT49.619.948.941.219.110.015.213.815.272.814.6
What You Get           
Rev Chg Q14.0%7.3%55.6%22.7%17.5%30.3%28.0%-1.4%10.3%31.0%8.9%
Rev Chg LTM8.0%5.5%71.6%31.0%19.8%10.6%28.8%-0.0%15.8%34.3%4.5%
Rev Chg 3Y Avg9.7%5.2%92.0%17.3%35.5%14.8%27.1%4.1%1.4%20.0%0.6%
FCF/Rev 3Y Avg23.4%57.4%41.3%39.3%37.3%35.9%54.2%32.9%26.1%25.8%20.4%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 24%, alpha of 2.9%, and sharpe of 1.04

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Synopsys Earnings Notes  
2ORCL, CRM Beat Synopsys Stock on Price & GrowthActionable 
3How Low Can Synopsys Stock Really Go?Return 
4Synopsys vs Oracle: Which Stock Could Rally?Counter-Intuitive Comparisons 
5Wait For A Dip To Buy Synopsys StockBuy or Fear 
6SNPS at Support Zone - Time to Buy?Actionable 
7SNPS Dips 32% In One Month: Does It Lead the Pack?  
8Is The 30.0% Decline In Synopsys (SNPS) Stock A Dip Buying Opportunity?Actionable 
9SNPS's 36% One Day Dip Begs The Question: Is ORCL Better Instead?Counter-Intuitive Comparisons 
10Better Bet Than SNPS Stock: Pay Less Than Synopsys To Get More From NVDA, MSFT   
11ARTICLES  
12Why ORCL, CRM Could Outperform Synopsys Stock October 23rd, 2025
13S&P 500 Movers | Winners: PEP, MKTX, AZO | Losers: SNPS, MOS, TER October 13th, 2025
14Is SNPS Stock A Buy? October 13th, 2025
15Big Decline for SNPS, but Do ORCL’s Margins and Growth Give It the Edge? October 4th, 2025
16SNPS Lost 22% In A Month. Do You Buy Or Wait? October 4th, 2025

Trade Ideas

Select past ideas related to SNPS. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ZBRA_10312025_Dip_Buyer_FCFYield10312025ZBRAZebra TechnologiesDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		0.0%0.0%0.0%
ACN_10312025_Dip_Buyer_ValueBuy10312025ACNAccentureDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		0.0%0.0%0.0%
ADBE_10312025_Dip_Buyer_ValueBuy10312025ADBEAdobeDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		0.0%0.0%0.0%
TXN_10312025_Monopoly_xInd_xCD_Getting_Cheaper10312025TXNTexas InstrumentsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.0%0.0%0.0%
MRVL_10242025_Monopoly_xInd_xCD_Getting_Cheaper10242025MRVLMarvell TechnologyMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		11.4%11.4%0.0%
SNPS_2282025_Monopoly_xInd_xCD_Getting_Cheaper02282025SNPSSynopsysMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		32.0%-0.8%-16.7%
SNPS_10312022_Monopoly_xInd_xCD_Getting_Cheaper10312022SNPSSynopsysMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		27.0%60.5%-5.5%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ZBRA_10312025_Dip_Buyer_FCFYield10312025ZBRAZebra TechnologiesDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		0.0%0.0%0.0%
ACN_10312025_Dip_Buyer_ValueBuy10312025ACNAccentureDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		0.0%0.0%0.0%
ADBE_10312025_Dip_Buyer_ValueBuy10312025ADBEAdobeDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		0.0%0.0%0.0%
TXN_10312025_Monopoly_xInd_xCD_Getting_Cheaper10312025TXNTexas InstrumentsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.0%0.0%0.0%
MRVL_10242025_Monopoly_xInd_xCD_Getting_Cheaper10242025MRVLMarvell TechnologyMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		11.4%11.4%0.0%
SNPS_2282025_Monopoly_xInd_xCD_Getting_Cheaper02282025SNPSSynopsysMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		32.0%-0.8%-16.7%
SNPS_10312022_Monopoly_xInd_xCD_Getting_Cheaper10312022SNPSSynopsysMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		27.0%60.5%-5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1PUMPProPetro64.5%11.3%
2VTYXVentyx Biosciences46.8%289.5%
3INBXInhibrx Biosciences42.5%430.3%
4RNAAvidity Biosciences42.1%140.2%
5GCIGannett40.6%4.7%
6CSIQCanadian Solar38.4%86.7%
7DYNDyne Therapeutics31.9%-4.2%
8ZBIOZenas BioPharma30.8%281.6%
9IMVTImmunovant30.3%-0.4%
10BBNXBeta Bionics29.9% 

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1LRNStride-55.3%-34.5%
2NTLAIntellia Therapeutics-50.7%8.2%
3FMCFMC-50.2%-67.4%
4FIFiserv-46.7%-67.5%
5VRNSVaronis Systems-43.5%-20.7%
6ATGEAdtalem Global Education-35.9%7.9%
7UAMYUnited States Antimony-32.8%355.9%
8SVVSavers Value Village-31.7%-10.1%
9NWLNewell Brands-31.7%-64.6%
10AKBAAkebia Therapeutics-27.1%16.3%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines260.1%158.3%
2VTYXVentyx Biosciences141.6%289.5%
3INBXInhibrx Biosciences132.9%430.3%
4TMQTrilogy Metals112.9%283.6%
5REPLReplimune109.2%-19.7%
6PUMPProPetro93.3%11.3%
7VICRVicor85.6%87.8%
8DYNDyne Therapeutics79.9%-4.2%
9GLUEMonte Rosa Therapeutics68.4%85.2%
10NVTSNavitas Semiconductor64.2%277.0%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1LRNStride-53.2%-34.5%
2FMCFMC-51.7%-67.4%
3FIFiserv-47.0%-67.5%
4SOCSable Offshore-46.5%-54.3%
5VRNSVaronis Systems-40.8%-20.7%
6OGNOrganon-38.3%-53.7%
7NTLAIntellia Therapeutics-38.3%8.2%
8VGVenture Global-37.8% 
9ITGRInteger-37.4%-51.3%
10NWLNewell Brands-34.7%-64.6%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1PUMPProPetro64.5%11.3%
2VTYXVentyx Biosciences46.8%289.5%
3INBXInhibrx Biosciences42.5%430.3%
4RNAAvidity Biosciences42.1%140.2%
5GCIGannett40.6%4.7%
6CSIQCanadian Solar38.4%86.7%
7DYNDyne Therapeutics31.9%-4.2%
8ZBIOZenas BioPharma30.8%281.6%
9IMVTImmunovant30.3%-0.4%
10BBNXBeta Bionics29.9% 

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1LRNStride-55.3%-34.5%
2NTLAIntellia Therapeutics-50.7%8.2%
3FMCFMC-50.2%-67.4%
4FIFiserv-46.7%-67.5%
5VRNSVaronis Systems-43.5%-20.7%
6ATGEAdtalem Global Education-35.9%7.9%
7UAMYUnited States Antimony-32.8%355.9%
8SVVSavers Value Village-31.7%-10.1%
9NWLNewell Brands-31.7%-64.6%
10AKBAAkebia Therapeutics-27.1%16.3%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Synopsys

Financials

SNPSAMDADSKRMBSBIYABLIVMedian
NameSynopsys Advanced.Autodesk Rambus Baiya In.BeLive  
Mkt Price453.82256.12301.34102.840.303.60179.48
Mkt Cap72.7415.764.211.1--68.4
Rev LTM6,43529,6006,605678--6,520
Op Inc LTM1,1042,4531,515247--1,310
FCF LTM1,3024,0431,847292--1,575
FCF 3Y Avg1,3002,4221,704220--1,502
CFO LTM1,4424,8771,925319--1,683
CFO 3Y Avg1,4613,0631,775246--1,618

Growth & Margins

SNPSAMDADSKRMBSBIYABLIVMedian
NameSynopsys Advanced.Autodesk Rambus Baiya In.BeLive  
Rev Chg LTM8.0%27.2%13.8%31.0%--20.5%
Rev Chg 3Y Avg9.7%11.7%11.7%17.3%--11.7%
Rev Chg Q14.0%31.7%17.1%22.7%--19.9%
QoQ Delta Rev Chg LTM3.4%6.7%4.1%5.1%--4.6%
Op Mgn LTM17.2%8.3%22.9%36.5%--20.0%
Op Mgn 3Y Avg21.6%3.4%21.5%27.8%--21.6%
QoQ Delta Op Mgn LTM-3.7%-2.0%0.8%0.2%---0.9%
CFO/Rev LTM22.4%16.5%29.1%47.0%--25.8%
CFO/Rev 3Y Avg26.3%11.9%30.7%44.2%--28.5%
FCF/Rev LTM20.2%13.7%28.0%43.1%--24.1%
FCF/Rev 3Y Avg23.4%9.3%29.5%39.3%--26.5%

Valuation

SNPSAMDADSKRMBSBIYABLIVMedian
NameSynopsys Advanced.Autodesk Rambus Baiya In.BeLive  
Mkt Cap72.7415.764.211.1--68.4
P/S11.314.09.716.3--12.7
P/EBIT49.6167.845.441.2--47.5
P/E36.4146.761.548.4--55.0
P/CFO50.485.233.334.7--42.5
Total Yield2.7%0.7%1.6%2.1%--1.8%
Dividend Yield0.0%0.0%0.0%0.0%--0.0%
FCF Yield 3Y Avg1.7%1.1%3.3%3.3%--2.5%
D/E0.20.00.00.0--0.0
Net D/E0.2-0.00.0-0.1--0.0

Returns

SNPSAMDADSKRMBSBIYABLIVMedian
NameSynopsys Advanced.Autodesk Rambus Baiya In.BeLive  
1M Rtn-3.7%50.9%-6.1%-0.8%-49.0%-5.3%-4.5%
3M Rtn-26.6%49.2%1.5%42.0%-56.5%53.2%21.7%
6M Rtn-3.9%159.2%7.6%100.5%-92.3%-22.1%1.9%
12M Rtn-12.5%80.5%5.2%114.5%--42.8%
3Y Rtn61.4%336.8%51.1%207.8%--134.6%
1M Excs Rtn-5.5%49.0%-8.0%-2.7%-50.8%-7.1%-6.3%
3M Excs Rtn-36.7%36.8%-8.4%27.7%-66.2%34.2%9.6%
6M Excs Rtn-24.2%138.9%-12.7%80.2%-112.6%-42.4%-18.4%
12M Excs Rtn-31.5%36.8%-13.2%84.4%--11.8%
3Y Excs Rtn-23.5%250.2%-38.1%175.4%--76.0%

Comparison Analyses

Title
0Synopsys vs. Paychex: With Return Forecast Of 18%, Synopsys Is A Better Bet
1Synopsys vs. Fortinet: With Return Forecast Of 43%, Fortinet Is A Better Bet
2Synopsys vs. Digital Realty Trust: With Return Forecast Of 18%, Synopsys Is A Better Bet
3Synopsys vs. O'Reilly Automotive: With Return Forecast Of 18%, Synopsys Is A Better Bet
4Synopsys vs. Airbnb: With Return Forecast Of 54%, Airbnb Is A Better Bet
5Synopsys vs. 3M: With Return Forecast Of 18%, Synopsys Is A Better Bet
6Synopsys vs. ServiceNow: With Return Forecast Of 42%, ServiceNow Is A Better Bet
7Synopsys vs. Welltower: With Return Forecast Of 40%, Welltower Is A Better Bet
8Synopsys vs. Quanta Services: With Return Forecast Of 46%, Quanta Services Is A Better Bet
9Synopsys vs. Northrop Grumman: With Return Forecast Of 20%, Synopsys Is A Better Bet

Financials

$ Mil | FY: 10/312025Q32025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q4
Period End7/31/20254/30/20251/31/202510/31/20247/31/20244/30/20241/31/202410/31/20237/31/20234/30/20231/31/202310/31/2022
Filing Date9/9/20255/28/20252/26/202512/19/20248/23/20245/24/20242/23/202412/12/20238/18/20235/19/20232/17/202312/12/2022
Key Financials Quarterly            
Total Revenue1,7401,6041,4551,6361,5261,4551,5111,4671,3541,2631,361818
Ebitda450539350452460410522471389357337259
Operating Income165376252311360332353423322287297203
Net Income2433452961,114408292449349336273272154
EPS1.512.231.917.242.661.912.952.302.211.791.781.00
Key Financials TTM            
Total Revenue TTM6,4356,2216,0726,1275,9595,7875,5965,4464,7974,6904,7074,616
Ebitda TTM1,7921,8021,6721,8441,8621,7911,7381,5531,3411,2471,2811,334
Operating Income TTM1,1041,2991,2551,3561,4681,4291,3841,3281,1091,0211,0981,160
Net Income TTM1,9982,1632,1102,2631,4981,4271,4071,2301,034921942985
Growth Rates Quarterly            
Total Revenue Growth14.0%10.3%-3.7%11.5%12.7%15.2%11.0%79.3%8.5%-1.3%7.2%-29.0%
EBITDA Growth-2.1%31.7%-33.0%-4.0%18.2%14.9%54.9%81.8%32.1%-8.7%-13.5%2.6%
Operating Income Growth-54.1%13.4%-28.6%-26.5%11.9%15.8%18.8%108.1%37.6%-21.2%-17.3%-2.6%
Net Income Growth-40.6%18.2%-34.2%219.1%21.4%7.0%65.4%127.5%51.0%-7.4%-13.4%-23.8%
Margins Quarterly            
EBITDA Margin25.9%33.6%24.0%27.7%30.1%28.2%34.5%32.1%28.7%28.2%24.7%31.7%
Operating Income Margin9.5%23.5%17.3%19.0%23.6%22.8%23.3%28.8%23.8%22.7%21.8%24.8%
Net Income Margin13.9%21.5%20.3%68.1%26.7%20.1%29.7%23.8%24.8%21.6%19.9%18.8%
Cash & Debt            
Total Cash2,59414,2643,8094,0501,9941,6601,2731,5861,8351,6951,3021,566
Total Debt15,14010,742665684674645670678689690690656
Net Debt / (Cash)12,547-3,522-3,144-3,366-1,320-1,015-603-908-1,145-1,006-611-909
Cash Flows Quarterly            
FCF from Operations671275-67563455477-88326560703115394
Cash Flows TTM            
FCF from Operations TTM1,4421,2261,4271,4071,1701,2741,5011,7031,7711,6511,6981,739
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases-0-0-0-0-0-0-0300300300261383
Return on Invested Capital (ROIC) Quarterly            
ROIC2.2%-----------
Return on Invested Capital (ROIC) TTM            
ROIC TTM3.6%-----------

Price Behavior

SNPS Betas & Captures as of 10/31/2025

 1M2M3M6M1Y3Y
Beta2.312.622.191.681.371.46
Up Beta2.145.383.511.811.321.41
Down Beta3.493.212.852.831.281.40
Up Capture67%-33%5%73%140%353%
Bmk +ve Days14273774145425
Stock +ve Days11222966127398
Down Capture229%257%231%140%132%109%
Bmk -ve Days9172853106327
Stock -ve Days12223660123353

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity4,241,124
Short Interest: % Change Since 9302025-12.5%
Average Daily Volume2,265,493
Days-to-Cover Short Interest1.87
Basic Shares Quantity160,174,000
Short % of Basic Shares2.6%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
9/9/2025-35.8%-29.5%-19.0%
5/28/2025-1.6%2.3%8.7%
2/26/2025-3.3%-4.8%-5.2%
12/4/2024-12.4%-12.9%-14.8%
8/21/2024-2.9%-9.7%-10.3%
5/22/20242.3%-1.5%3.9%
2/21/20246.9%4.9%10.8%
11/29/2023-1.7%-4.5%-6.8%
...
SUMMARY STATS   
# Positive111213
# Negative131211
Median Positive5.4%5.0%10.1%
Median Negative-3.3%-5.3%-10.3%
Max Positive10.3%11.8%17.0%
Max Negative-35.8%-29.5%-30.3%

SEC Filings

Expand for More

Report DateFiling DateFiling
7312025909202510-Q 7/31/2025
4302025528202510-Q 4/30/2025
1312025226202510-Q 1/31/2025
103120241219202410-K 10/31/2024
7312024823202410-Q 7/31/2024
4302024524202410-Q 4/30/2024
1312024223202410-Q 1/31/2024
103120231212202310-K 10/31/2023
7312023818202310-Q 7/31/2023
4302023519202310-Q 4/30/2023
1312023217202310-Q 1/31/2023
103120221212202210-K 10/31/2022
7312022819202210-Q 7/31/2022
4302022520202210-Q 4/30/2022
1312022218202210-Q 1/31/2022
103120211213202110-K 10/31/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value		Value of
Held Shares		Form
0PAINTER ROBERT G 9152025Buy425.44350148,904974,682Form
1MAHONEY RICHARD S.Chief Revenue Officer6202025Sell471.194,8692,294,220699,716Form

External Quote Links


Prefer one of these to Trefis? Tell us why.